416 related articles for article (PubMed ID: 19077816)
1. Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?
Ehrlich JR; Nattel S
Curr Opin Cardiol; 2009 Jan; 24(1):50-5. PubMed ID: 19077816
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
Krishnamoorthy S; Lip GY
Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
[TBL] [Abstract][Full Text] [Related]
3. Vernakalant hydrochloride for the treatment of atrial fibrillation.
Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
Expert Opin Investig Drugs; 2009 Dec; 18(12):1929-37. PubMed ID: 19938903
[TBL] [Abstract][Full Text] [Related]
4. The pharmaceutical pipeline for atrial fibrillation.
Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
[TBL] [Abstract][Full Text] [Related]
5. Dronedarone: a novel antiarrhythmic agent for the treatment of atrial fibrillation.
Duray GZ; Ehrlich JR; Hohnloser SH
Curr Opin Cardiol; 2010 Jan; 25(1):53-8. PubMed ID: 19881340
[TBL] [Abstract][Full Text] [Related]
6. New antiarrhythmic drugs for treatment of atrial fibrillation.
Dobrev D; Nattel S
Lancet; 2010 Apr; 375(9721):1212-23. PubMed ID: 20334907
[TBL] [Abstract][Full Text] [Related]
7. [Vernakalant: a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm].
Hirt MN; Eschenhagen T
Dtsch Med Wochenschr; 2010 May; 135(19):971-6. PubMed ID: 20446233
[TBL] [Abstract][Full Text] [Related]
8. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
Pamukcu B; Lip GY
Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
[TBL] [Abstract][Full Text] [Related]
9. New anthyarrhythmic drugs for atrial fibrillation.
Matassini MV; Guerra F; Scappini L; Urbinati A; Capucci A
Future Cardiol; 2015; 11(6):705-17. PubMed ID: 26631497
[TBL] [Abstract][Full Text] [Related]
10. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
Dale KM; White CM
Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667
[TBL] [Abstract][Full Text] [Related]
11. Dronedarone: an emerging therapy for atrial fibrillation.
Rosei EA; Salvetti M
Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
[TBL] [Abstract][Full Text] [Related]
12. Dronedarone.
Patel C; Yan GX; Kowey PR
Circulation; 2009 Aug; 120(7):636-44. PubMed ID: 19687370
[TBL] [Abstract][Full Text] [Related]
13. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
14. Vernakalant in the management of atrial fibrillation.
Cheng JW
Ann Pharmacother; 2008 Apr; 42(4):533-42. PubMed ID: 18334607
[TBL] [Abstract][Full Text] [Related]
15. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
[TBL] [Abstract][Full Text] [Related]
16. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
[TBL] [Abstract][Full Text] [Related]
17. Dronedarone for atrial fibrillation therapy.
Marzocchi M; Lombardi F
Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598
[TBL] [Abstract][Full Text] [Related]
18. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
Garcia D; Cheng-Lai A
Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
[TBL] [Abstract][Full Text] [Related]
19. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
Wegener FT; Ehrlich JR; Hohnloser SH
J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
[TBL] [Abstract][Full Text] [Related]
20. [Vernakalant--a new drug for pharmacological conversion of atrial fibrillation].
Hinneburg I
Med Monatsschr Pharm; 2011 May; 34(5):154-8. PubMed ID: 21644373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]